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The Effect of Prophylactic Therapy with Valproate Sodium in
Japanese Children with Cyclic Vomiting Syndrome
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Fumiaya Kaga, Kaori Amakata, Kaori Ogita, Yasushi Fujii,
Yukishige Yanagawa
Dept. of Pediatrics, Teikyo University School of Medicine, Japan
E-mail address: sono-1214-yosm@tcn-catv.ne.jp
Background: Cyclic vomiting syndrome (CVS) is characterized by
recurrent, stereotypic episodes of incapacitating nausea, vomiting, and
other symptoms, separated by intervals of comparative wellness. The
second edition of the International Headache Classiﬁcation classiﬁes
CVS as the subgroup of childhood periodic syndromes, which are
common precursors of migraine. CVS may respond to migraine-
directed prophylactic agents such as beta-blockers, amitriptyline, and
cyproheptadine. Since 1988, valproate has been prescribed for migraine
prophylaxis. The aim of this therapeutic trial was to evaluate the use
of valproate, an antimigraine prophylactic drug, for the prophylactic
management of CVS in children. We used prophylactic therapy in patients
in whom the episodes of CVS occurred more-than-once a month and/or
who particularly has severe and disabling episodes.
Methods: The nature of the trial and the possible side effects of the
drug were explained to the prospective participants, i.e., parents as well
as patients. After receiving an informed consent, 13 children diagnosed
with severe CVS were enrolled in the study. Prophylactic therapy
consisted of valproate administered at a dose of 10 40mg. All patients
underwent diagnostic tests to rule out organic causes of their symptoms.
Vomiting was severe enough in all patients to cause dehydration requiring
hospitalization for intravenous rehydration. Electroencephalogram (EEG)
showed spikes or spike-wave complexes in two patients, and normal EEG
in the remaining patients. Nine of the 13 patients did not respond to
medical therapies such as propranolol, amitriptyline, cyproheptadine,
phenobarbital, phenytoin, and carbamazepine. Three patients required
combination therapy with valproate and phenobarbital.
Results: Of the 13 patients, two showed complete resolution of their
symptoms; nine showed marked improvement, which was evidenced
by a low number of attacks with reduced severity; and two failed to
respond to valproate therapy. Four patients experienced relapse with a
decreased dosage of valproate. Side effects associated with long-term
valproate administration were not observed, with the exception of mild
liver dysfunction.
Conclusions: Valproate appears to be effective for the prophylactic
management of severe CVS, with 85% of all patients achieving a reduction
in the frequency of attacks.
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System Infection-Related Epilepsy
Soochul Park1 *, Joo-Hyun Seo1, Bosuk Park1, Moon Kyu Lee1,
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Background: Central nervous system (CNS) commonly resulted in
encephalomalacia (ECM) and/or hippocampal sclerosis (HS), which was
relevant lesion of chronic epilepsy. The signiﬁcance of the prognostic
impact of HS in CNS infection-related epilepsy has not been studied. We
tried to study the prognostic impact of HS irrespective of ECM in central
nervous system infection-related epilepsy.
Methods: Total 102 epilepsy patients with antecedent history of
meningoencephalitis were recruited. Those were divided into as
followings; 35 patients with unilateral isolated HS as group A. 24 patients
with ECM in addition to unilateral HS as group B, 22 patients with no lesion
on brain MRI as group C, 21 patients with ECM lesion only as group D.
Prognostic impact depending on the presence of HS was compared
between group A and C. Comparison was also done between group B
and D. Finally, analysis depending on the presence of HS, irrespective
of ECM, was done. Age at onset of epilepsy, age of infection, clinical
variables with neurologic status, clinical characteristics of seizure, and
semiologic features of temporal lobe epilepsy (TLE) were analyzed.
Prognosis with a follow-up duration of at least two years was analyzed.
Results: Comparison of clinical variables between group A and C showed
that semiological features of TLE were signiﬁcantly prominent in group A,
but 2′ GTC and nocturnal dominance were more in group C. In the analysis
depending on the presence of HS irrespective of ECM, semiological
features of TLE were statistically prominent in group with HS but 2′ GTC
was more in group without HS. There was no statistically signiﬁcant
difference in prognosis between any comparisons.
Conclusions: In general consideration of the poor prognostic impact of
HS in epilepsy, the presence of HS in CNS infection-related epilepsy
irrespective of the underlying ECM did not make statistically signiﬁcant
impact on the prognosis of CNS infection-related epilepsy.
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Clinical Spectrum of Pseudo Seizures at a Tertiary Care Hospital
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Nadeem Ahmed Memon1,2 *, Bhojo A. Khealani1,2, Fazal Karim1,
Mustafa Khan1, Nadir Ali Syed2, Saad Shafqat1,2
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Background: Nonepileptic seizures are involuntary episodes of move-
ment, sensation, or behaviors (e.g., vocalization, crying and other
expressions of emotion), that do not result from abnormal cortical
discharges. The events typically occur in teenage patients with anxiety
and affective disorders. Psychotherapy, behavioral therapy, drugs,
hypnosis and placebo are mainstay of treatment. There is no published
data on clinical characteristics of pseudo-seizures from Pakistan. The
objective of our study is to describe the clinical characteristics of pseudo-
seizures in a tertiary care hospital in Karachi, Pakistan.
Methods: This is a descriptive study. Patients with pseudo-seizures were
identiﬁed from departmental Video EEG monitoring register, over a period
of three years (2004 2006). Their neurophysiologic and video recording
data was reviewed and their demographic, clinical and neurophysiologic
data was recorded and analyzed. SPSS version 15.0 was used for analysis.
Results: A total of 132 patients underwent video EEG during the period
and 51 (38%) had pseudo-seizures. Their mean age was 26.7±15.3 years.
Thirty-two (63%) were female and 19 (37%) were male. Twelve (23.5%)
patients were known epileptics. Median recording time was 24 (range;
0.33 55) hours and median number of events was 3 (range; 1 14).
Limb movements were most common manifestation (67%) followed
by muteness with no response to verbal commands (49%), behavioral
symptoms (35.5%), ocular ﬁndings i.e. eye blinking and closure (25.5%),
depressed conscious level (13.7%), headache (10%) and GI symptoms
(10%). Six (11.8%) patients experienced epileptic seizures, in addition
to pseudo-seizures.
Conclusions: Pseudo-seizures are common in patients referred for video
EEG monitoring. It is more common in young women. Limb movements,
muteness and behavioral symptoms are most common manifestations.
The pseudo-seizures and epileptic seizures may coexist in the same
patient.
